Resource Center
Resource Center
CHAI has published the 2022 Hepatitis B Market Report, which covers the latest trends in the hepatitis B diagnostic and treatment markets.
Read moreReproductive Health Supplies Coalition and CHAI have released the 2022 Family Planning Market Report which provides the global community with the most comprehensive and reliable view into the public sector of the family planning procurement market across 83 low- and lower-middle-income countries.
Read moreCHAI has released the 13th issue of our annual HIV market report detailing the complex, ever-changing HIV commodity markets in low- and middle-income countries based on aggregated market intelligence from our work in over 20 countries.
Read moreCHAI has published the Advanced HIV Disease (AHD) Impact Report, providing a detailed look at progress made since 2019 to avert preventable deaths among people with AHD.
Read moreCHAI is excited to publish the 2022 Hepatitis C Market Memo, covering the latest trends in the hepatitis C diagnostics and treatment markets. The memo provides updates on key innovations, volume, and pricing trends for hepatitis programs seeking to eliminate the disease.
Read moreIntroducing the sixth edition of CHAI’s HIV Mid-Year Market Memo, a brief that covers the latest trends in the HIV space in low- and middle-income countries since the publication of CHAI’s annual HIV Market Report in September 2021.
Read moreThis webinar, recorded Nov. 4, 2021, highlights key trends in CHAI’s annual HIV Market Report, which provides a detailed look at the complex, ever-changing HIV commodity markets in low- and middle-income countries based on aggregated market intelligence from our work in over 30 countries.
Read moreThis report helps donors and buyers in public health better understand the offerings of respiratory equipment suppliers based in sub-Saharan Africa.
Read moreCHAI releases the 12th issue of our annual HIV market report. This report provides a detailed look at the complex, ever-changing HIV commodity markets in low- and middle-income countries based on aggregated market intelligence from our work in over 30 countries.
Read moreThe report is the first of its kind providing market intelligence on the current state of access to blood glucose self-monitoring devices in low- and middle-income countries.
Read more